13, 14 However, serious problems are rare
Report it to the brand, retailer, or the MHRAs Yellow Card Scheme if youre in the UK
GLP-1 therapy is generally recommended for individuals diagnosed with type 2 diabetes who require additional glycemic control, patients with a body mass index (BMI) greater than 27, especially those with weight-related comorbidities, and those not achieving target blood glucose levels with metformin or other oral hypoglycemic agents
Four studies (36%) reported elevated opioid peptide levels (Pedersen et al
New studies showed that semaglutide (Ozempic) may help reduce the progression of kidney disease in people with type 2 diabetes, and it may also help protect kidney function in people who are overweight or obese with established cardiovascular disease
With these drugs, the long-term dental data is missing, so its premature to consider Ozempic mouth as a definite thing, explains the BDAs scientific adviser, Dr Praveen Sharma, an associate professor and honorary consultant in restorative dentistry at the University of Birmingham